Is WELL Health (TSX:WELL) Stock Still a Multi-Bagger?

WELL Health Technologies (TSX:WELL) stock still has plenty of room for growth.

| More on:

Have investors missed the boat on lucrative growth opportunities? In 2020, growth stocks like WELL Health Technologies (TSX:WELL) delivered extraordinary returns. This year, the stock market is much more muted. Growth stocks have struggled, and even the reopening play seems to have tapped out. 

It’s a different economic environment. But that doesn’t mean WELL Health stock and other long-term growth plays can’t deliver multi-bagger returns. Here are the top three reasons why I believe the WELL Health growth story is far from over. 

Telehealth is here to stay

Some pandemic trends are here to stay. Telehealth, in my opinion, is one of them. Why would you give up the convenience of speaking with a medical professional remotely? Some medical conditions and emergencies certainly need physical attention, but for general advice and prescriptions, a quick text or video call should be enough. 

Telehealth has vastly improved access to healthcare for millions over the past year. WELL Health’s VirtualClinic+ saw tremendous growth over 2020. This pace of adoption should continue, as more people recognize the value of telehealth in the years ahead. 

The U.S. healthcare market is worth trillions

The acquisition of Silicon Valley-based Circle Medical Technologies gave WELL Health access to the American healthcare market. Healthcare services are expected to generate US$4.3 trillion (CA$5.5 trillion) by 2023. Much of that sector is still based on legacy systems and outdated infrastructure. 

In other words, WELL Health has a trillion-dollar opportunity to expand its network of private clinics, medical data software and telehealth services across the continent. This vast opportunity isn’t fully reflected in the company’s market value. 

WELL Health stock is undervalued

WELL Health stock currently trades at $7.5 — 15% below its all-time high. It’s still up 6,700% over the past five years, making it one of the best-performing tech stocks in Canada. 

With recent acquisitions, the WELL Health team believes they can push annual revenue run rate beyond $400 million. Meanwhile, the company is worth just $1.47 billion. In other words, the price-to-sales ratio is roughly 3.67. That’s far lower than most tech or software stocks on the market right now. 

WELL Health could certainly be a multi-bagger if the valuation is readjusted. The company’s American peers trade at price-to-sales ratios of 15 to 17. 

The team could also unlock substantial gains through mega-mergers. WELL Health has $83.25 million in cash and cash equivalents on its books. Debt is relatively low, which means there’s room to add cheap, borrowed capital. Meanwhile, major investors such as Sir Li Ka-Shing could certainly support future acquisitions and med-deals. 

This growth story is simply too compelling to ignore. 

Bottom line

Growth stocks have had a rough ride this year. Most are trading below all-time highs. WELL Health stock is roughly 15% cheaper than it was just a few months ago. However, the growth story is as strong as ever, and the stock could be a multi-bagger if it simply receives a justified valuation. Keep an eye on this opportunity. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Vishesh Raisinghani  owns shares of WELL Health Technologies. 

More on Tech Stocks

a-developer-typing-lines-of-ai-code-while-viewing-multiple-computer-monitors
Tech Stocks

Could Constellation Software Become the Next Berkshire Hathaway?

Constellation Software's (TSX:CSU) capital-allocation strategy is similar to that of Berkshire Hathaway (NYSE:BRK.B).

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy With $1,000 Right Now

These three Canadian tech stocks could be among the best growth opportunities in the market right now.

Read more »

happy woman throws cash
Tech Stocks

3 Growth Stocks That Could Be Long-Term Wealth Creators

These three growth stocks aim to grow their financials at a higher rate than the industry average, thus delivering superior…

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is POET Technologies a Top AI Stock for Canadian Investors?

Canada has relatively few AI stocks, and the ones it has are different from American AI stocks in terms of…

Read more »

Rocket lift off through the clouds
Tech Stocks

2 Growth Stocks That Could Skyrocket in 2025 and Beyond

Wondering what types of stocks could rapidly rise in 2025? Check out these two stocks with substantial upside if they…

Read more »

up arrow on wooden blocks
Tech Stocks

The 3 Smartest Tech Stocks to Buy With $500 Right Now

Tech stocks can be seen as a bit risky, but these three have far less risk and more stability for…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Tech Stocks

Shopify: A Must-Have Growth Stock for Your TFSA Now (and the Next 10 Years)

Shopify (TSX:SHOP) stock isn't just a top growth company, it's a titan worth owning in your decades-long TFSA fund.

Read more »

cloud computing
Tech Stocks

Best Stock to Buy Right Now: Manulife vs CIBC

Want the best stocks? These two are certainly the best options. But which is the better buy?

Read more »